Matus-Santos J, Motola-Kuba D

Idioma: Español
Referencias bibliográficas: 36
Paginas: 222-227
Archivo PDF: 111.13 Kb.

RESUMEN

La metástasis a nivel del sistema nervioso central ha demostrado disminuir de forma importante el pronóstico de sobrevivencia de los pacientes con cáncer. Los principales carcinomas que desarrollan metástasis a nivel del sistema nervioso central son los tumores de pulmón, riñón, mama, melanoma y cáncer colorrectal. En este artículo se presenta una revisión de la importancia de la metástasis a nivel del sistema nervioso central en el diagnóstico o durante la evolución de una neoplasia maligna.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Waerzeggers Y, Rahbar K, Riemann B, Weckesser M, Schafers M, Hesselmann V, Niederstadt T, et al. PET in the diagnosis and management of patients with brain metastasis: current role and future perspectives. Cancer Biomark 2010; 7: 219-33.

2. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005; 75: 5-14.

3. Johnson JD, Young B. Demographics of brain metastasis. Neurosurg Clin N Am 1996; 337-44.

4. Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007; 48: 1468-81.

5. Salvati M, Frati A, D’Elia A, Pescatori L, Piccirilli M, Pietrantonio A, Fazi M, et al. Single brain metastases from melanoma: remarks on a series of 84 patients. Neurosurgical review 2011.

6. WMc DAJLM. Metastatic Cancer to the Brain. In: Cancer: Principles and Practice of Oncology. Philadelphia: ed. H.R.s. Devita; 2008.

7. Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ. Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 2005; 5: 108-13.

8. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004; 22: 2865-72.

9. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002; 94: 2698-705.

10. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978; 42: 660-8.

11. Lassman AB, DeAngelis LM. Brain metastases. Neurologic clinics 2003; 21: 1-23, vii.

12. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol 1988; 45: 741-4.

13. Clouston PD, DeAngelis LM, Posner JB. The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 1992; 31: 268-73.

14. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology 1993; 43: 1678-83.

15. Cohen N, Strauss G, Lew R, Silver D, Recht L. Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988; 6: 1621-4.

16. Coia LR, Aaronson N, Linggood R, Loeffler J, Priestman TJ. A report of the consensus workshop panel on the treatment of brain metastases. Int J Radiat Oncol Biol Phys 1992; 23: 223-7.

17. Nutt SH, Patchell RA. Intracranial hemorrhage associated with primary and secondary tumors. Neurosurg Clin N Am 1992; 3: 591-9.

18. DeVita DVTL, T, Principles & Practice of Oncology. Vol. 2. 8th ed. Lippincott Williams & Wilkins; 2008.

19. Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 1990; 11: 785-91.

20. Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr. Diagnosis of cerebral metastases: double-dose delayed CT vs. contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991; 12: 293-300.

21. Schaefer PW, Budzik RF Jr., Gonzalez RG. Imaging of cerebral metastases. Neurosurg Clin N Am 1996; 7: 393-423.

22. Lee HY, Chung JK, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer. Ann Nucl Med 2008; 22: 281-6.

23. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494-500.

24. Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist 2007; 12: 884-98.

25. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745-51.

26. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999; 43: 795-803.

27. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004; 22: 1293- 300.

28. D’Addario G, Fruh M, Reck M, Baumann P, Klepetko W, Felip E. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v116-v119.

29. Sorensen M, Pijls-Johannesma M, Felip E. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals Oncol 2010; 21(Suppl. 5): v120-v125.

30. Escudier B, Kataja V. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v137-v139.

31. Cardoso F, Senkus-Konefka E, Fallowfield L, Costa A, Castiglione M. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v15-v19.

32. Cardoso F, Fallowfield L, Costa A, Castiglione M, Senkus E. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011; 22(Suppl. 6): vi25-vi30.

33. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, et al. Invasive breast cancer. J Natl Compr Canc Netw 2011; 9: 136-222.

34. Dummer R, Hauschild A, Guggenheim M, Jost L, Pentheroudakis G. Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v194- V197.

35. Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v70-v77.

36. Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, Dimaio D, Guild V, Halpern AC, et al. Melanoma. J Natl Compr Canc Netw 2009; 7: 250-75.